Mimi I. Hu

Mimi I. Hu is a Senior Professor at The University of Texas MD Anderson Cancer Center, specializing in endocrine oncology and thyroid cancer care. Her research focuses on advanced medullary and differentiated thyroid carcinoma, particularly mechanisms of resistance to selective RET inhibitors, acquired driver fusions, and BRAF/MEK inhibitor-associated cardiac dysfunction. She has developed a thyroid carcinoma-specific graded prognostic assessment for brain metastases, validated in a 10,306-patient cohort, and leads patient-centered initiatives such as MTCEducate.org, an online decision aid for medullary thyroid cancer. Her work includes secondary analyses of the LIBRETTO-531 trial and systematic reviews on whole-brain radiation therapy, advancing precision oncology and patient-reported outcomes in thyroid cancer.